Comparison of the efficacy of PSI, CURB-65, CALL and BCRSS in predicting prognosis and mortality in COVID-19 patients
Tam metin
Benzer Belgeler
11 Division of Nephrology, Department of Internal Medicine, University of Health Sciences, Bagcilar Training and Research Hospital, Istanbul, Turkey.. 12 Department of
1 Department of Hematology and Bone Marrow Transplantation Center, Ankara Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.. 2 Department
Hemoglobin, white blood cell (WBC) count, platelet count, transfusion requirements, duration of hospitalization, and frequency and duration of adverse events including
In conclusion, the present study showed that treatment costs in- crease with a prolonged length of stay in the ICU and it is more expensive to treat COVID-19 patients than
In the second month, statistically significant improvements con- tinued in walking VAS scores (p=0.007), flexion of the knee VAS scores (p=0.001), WOMAC pain scores (p=0.001), WOMAC
Comparison of D-dimer Level Measured on the Third Day of Hospitalization with Admission D-dimer Level in Predicting In-hospital Mortality in COVID-19 Patients.. COVID-19 Hastalarında
Objective: The present study aimed to compare the value of D-dimer measured on the 3rd day of hospitaliza- tion with admission D-dimer level in predicting in-hospital mortality
Methods: A total of 166 patients (65 at ICU, 101 at pandemic service) were analyzed to uncover effect of radiological and laboratory parameters on prognosis in COVID-19.. There was